Analyst Ratings for Ideaya Biosciences (IDYA)
IDYA Rating Summary
IDYA Price Target Summary
- Highest: $64.00 (Citi)
- Lowest: $35.00 (Goldman Sachs)
- Average: $50.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.38 (+45.2%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Avg. $ Target:
$50.38 (+45.2%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | William Blair | Alethia Young | New Coverage | Outperform (N/A) |
N/A (N/A) |
33.86 (34.71) |
2.51% | Details |
| 10/13/2026 | Stifel | Laura Prendergast | New Coverage | Buy (N/A) |
48.00 (N/A) |
36.06 (34.71) |
-3.74% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
